Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio A Mosse

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bone Marrow Transplantation|June 20, 2018
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapyC Amos Clark, Claudio A Mosse, Heidi Chen, et al.
Bone Marrow Transplantation|January 30, 2020
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myelomaDilan A Patel, Ragisha Gopalakrishnan, Brian G Engelhardt, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
The American Journal of Pathology|August 8, 2021
miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic SyndromesDahai Wang, Miao Lin, Begum Utz, et al.
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026William G Wierda, Jennifer Brown, Jeremy S Abramson, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bone Marrow Transplantation|June 20, 2018
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapyC Amos Clark, Claudio A Mosse, Heidi Chen, et al.
Bone Marrow Transplantation|January 30, 2020
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myelomaDilan A Patel, Ragisha Gopalakrishnan, Brian G Engelhardt, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
The American Journal of Pathology|August 8, 2021
miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic SyndromesDahai Wang, Miao Lin, Begum Utz, et al.
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026William G Wierda, Jennifer Brown, Jeremy S Abramson, et al.
Pageof 3